Clinical Trials Logo

Borderline Personality Disorder clinical trials

View clinical trials related to Borderline Personality Disorder.

Filter by:

NCT ID: NCT03123198 Active, not recruiting - Clinical trials for Borderline Personality Disorder

Dialectical Behavior Therapy Rutgers University Research Program

DBT-RU
Start date: March 2010
Phase: N/A
Study type: Interventional

This protocol establishes a research oriented psychological treatment clinic within the Graduate School of Applied and Professional Psychology (GSAPP), called the Dialectical Behavior Therapy Rutgers University Research Program (DBT-RU). The overall aim of the proposed research is to find ways to improve therapist training in existing treatments for complex and difficult-to-treat problems (e.g., DBT, prolonged exposure), develop new and more effective treatments, and improve understanding of severe psychopathology. Consequently, this proposed research will have four branches: (1) training of research clinicians and evaluation of training methods; (2) training of clinical evaluators for the research studies and evaluation of assessment training methods; (3) assessment of treatment outcome, including assessment of mediators and moderators of change (both clinician and client data); (4) assessment and analyses of psychopathology of subject populations who participate in the DBT-RU.

NCT ID: NCT03060902 Completed - Clinical trials for Borderline Personality Disorder

Preschooler Emotion Regulation in the Context of Maternal Borderline Personality Disorder

Start date: October 23, 2017
Phase: N/A
Study type: Interventional

Offspring of mothers with Borderline Personality Disorder (BPD) are at serious risk for developing mental illness at every stage of their life, and yet little is known about how this risk is transmitted. This study will leverage Dialectical Behavior Therapy Skills as an experimental intervention to determine if preschool emotion regulation develops more rapidly as a result of improvements in mothers' ability to regulate her own emotions. The knowledge from this study will identify a modifiable pathway by which maternal BPD places offspring at risk for later mental disorders and will quantify how much improvement in children's ability to regulate their emotions can be achieved by treating mothers alone.

NCT ID: NCT03018639 Completed - Clinical trials for PostTraumatic Stress Disorder

Impact of Therapist Change on Dropout in a Naturalistic Sample of Inpatients With Borderline Pathology Receiving DBT

Start date: December 2012
Phase: N/A
Study type: Observational

Participants with Borderline pathology (≥ 3 DSM-IV-criteria) receiving an inpatient Dialectical Behavior Therapy (DBT) program completed a quality assurance questionnaire set assessing demographic information and pretreatment psychopathology during the days of their inpatient stay. Beyond that, changes of therapists were documented.

NCT ID: NCT03011190 Completed - Clinical trials for Personality Disorder, Borderline

Effectiveness of the Iconic Therapy for Borderline Personality Disorder Symptoms

Start date: September 2015
Phase: N/A
Study type: Interventional

Borderline personality disorder (BPD) is the most prevalent personality disorder in young community population whose most severe complication is suicide. Pharmacotherapy should not be used as the primary treatment for BPD as the benefits are unclear. Psychotherapy is the main treatment for people with BPD and the current recommendation is adapting available comprehensive treatments to develop easier and briefer therapies that are also effective. Iconic Therapy is an innovative option whose good clinical results should be validated on a clinical trial.

NCT ID: NCT02988037 Completed - Clinical trials for Borderline Personality Disorder

Adapted Dialectical Behaviour Therapy for Adolescents With Deliberate Self-Harm: A Pre-post Observational Study

Start date: September 2012
Phase: N/A
Study type: Interventional

The investigators conducted a pre-post naturalistic study regarding changes observed associated with a 15-week course of an adapted form of dialectical behaviour therapy for adolescents. We measured frequency of self-harm prior to treatment and after treatment using the Self-Injurious Thoughts and Behaviors Interview. We also measured changes using the Suicide Ideation Questionnaire, Life Problems Inventory, Resiliency Scale for Children and Adolescents.

NCT ID: NCT02985047 Completed - Suicidal Ideation Clinical Trials

Brief Admission Skane: Replacing General Admission for Individuals With Self-harm and Acute Risk of Suicide

BAS
Start date: September 1, 2015
Phase: N/A
Study type: Interventional

The purpose of the study is to test a standardized version of brief admission (BA) through randomized controlled trial (RCT). The main objective is to evaluate if BA can serve as a crisis management model for individuals with recurrent self-harm, including suicide attempts and at least three symptoms of Borderline Personality disorder. Participants will be allocated to BA + Treatment as Usual (TAU) or TAU.

NCT ID: NCT02935218 Completed - Clinical trials for Borderline Personality Disorder

Parenting Skills for Mothers With Borderline Personality Disorder: A Newly Developed Group Training Program

Start date: January 2015
Phase: N/A
Study type: Interventional

N=15 mothers with Borderline Personality Disorder who had young children (aged 0-6 years) participated in a 12-week training program. To estimate the participants' impairment, parental stress and psychological distress were assessed before the training. After the training, participants and trainers were asked to provide feedback regarding the valuation of and the changes due to the training.

NCT ID: NCT02866110 Completed - Clinical trials for Borderline Personality Disorder

Training of Neural Responding in BPD

IP5n
Start date: October 2016
Phase: N/A
Study type: Interventional

Emotion-related brain activation is made visible for patients via neurofeedback with the aim to improve discriminability of emotional arousal and emotion regulation. With functional magnetic resonance imaging (fMRI), information of current brain activation is imaged and fed back to the patient via a visual display. Patients with borderline personality disorder (BPD) usually hyper-activate brain regions associated with emotion. In this study, BPD patients will be provided with neurofeedback from the amygdala, which is crucial for the processing of emotions. The aim of the study is to observe, whether amygdala-neurofeedback would help BPD patients to improve emotion regulation. Compared to a control condition, improved brain self-regulation and emotion regulation is expected with three neurofeedback training sessions.

NCT ID: NCT02849431 Withdrawn - Clinical trials for Borderline Personality Disorder

Mindfulness for Intense Emotions: A Feasibility Trial

MindIE
Start date: July 2016
Phase: N/A
Study type: Interventional

This study explores the feasibility of a mindfulness-based intervention for people with a diagnosis of borderline personality disorder.

NCT ID: NCT02829658 Completed - Clinical trials for Borderline Personality Disorder

Use of Care Services by Patients With Borderline Personality Disorder

EpiB
Start date: February 2009
Phase: N/A
Study type: Observational

Borderline personality disorder (BPD) is characterized by a pervasive pattern of instability and impulsivity. Several North American prospective studies support the high level of mental health care utilization in this population. There is little data in other systems of health organization, such as France. Furthermore, little is known on the variables associated with the mental health service utilization among BPD patients. The main objective was to compare the utilization of mental health care among BPD patients, to the general population and patients with another personality disorder (PD) and to describe the demographic and clinical factors associated with the group of patients who use the most health care.